Cross Country Healthcare (NASDAQ:CCRN – Get Free Report)‘s stock had its “market perform” rating restated by analysts at Barrington Research in a report issued on Monday,Benzinga reports. They presently have a $13.25 price target on the business services provider’s stock. Barrington Research’s target price would indicate a potential upside of 0.42% from the company’s previous close.
A number of other analysts have also commented on CCRN. Truist Financial lifted their price target on Cross Country Healthcare from $10.00 to $13.25 and gave the company a “hold” rating in a research note on Monday, May 11th. Cross Research set a $14.00 price objective on Cross Country Healthcare in a research note on Thursday, March 5th. Wedbush lowered Cross Country Healthcare from an “outperform” rating to a “hold” rating and cut their price objective for the stock from $15.00 to $13.25 in a research note on Thursday, May 7th. Weiss Ratings raised Cross Country Healthcare from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 27th. Finally, Citigroup lowered Cross Country Healthcare from a “market outperform” rating to a “market perform” rating in a research note on Thursday, May 7th. Nine equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Reduce” and an average target price of $12.05.
Check Out Our Latest Research Report on CCRN
Cross Country Healthcare Trading Up 0.1%
Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The business services provider reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02. Cross Country Healthcare had a negative return on equity of 0.74% and a negative net margin of 9.84%.The firm had revenue of $241.06 million for the quarter, compared to analyst estimates of $237.07 million. As a group, research analysts predict that Cross Country Healthcare will post 0.1 EPS for the current fiscal year.
Hedge Funds Weigh In On Cross Country Healthcare
A number of institutional investors and hedge funds have recently modified their holdings of the business. BNP Paribas Financial Markets increased its stake in shares of Cross Country Healthcare by 50.0% in the 2nd quarter. BNP Paribas Financial Markets now owns 3,424 shares of the business services provider’s stock valued at $45,000 after acquiring an additional 1,142 shares in the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in shares of Cross Country Healthcare in the 4th quarter valued at $46,000. Tower Research Capital LLC TRC increased its stake in shares of Cross Country Healthcare by 422.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 3,586 shares of the business services provider’s stock valued at $47,000 after acquiring an additional 2,899 shares in the last quarter. Graham Capital Management L.P. bought a new stake in shares of Cross Country Healthcare in the 4th quarter valued at $83,000. Finally, AXQ Capital LP bought a new stake in shares of Cross Country Healthcare in the 4th quarter valued at $109,000. 96.03% of the stock is currently owned by institutional investors.
About Cross Country Healthcare
Cross Country Healthcare, Inc, headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.
The company’s core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs.
Recommended Stories
- Five stocks we like better than Cross Country Healthcare
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
